Table 1.
Statistical properties of standardised time-on-treatment (τ) and cumulative dose (δ)
| Mean | SD | Min | Median | IQR | Max | ||
| Regimen-C (n=235) | τ | 1.36 | 0.47 | 0.00 | 1.464 | (1.34, 1.60) | 2.99 |
| δ | 0.84 | 0.22 | 0.17 | 0.94 | (0.78, 1.00) | 1.06 | |
| Regimen-DI (n=243) | τ | 1.15 | 0.35 | 0.00 | 1.22 | (1.07, 1.35) | 1.93 |
| δ | 0.87 | 0.19 | 0.17 | 0.96 | (0.82, 1.00) | 1.06 |
The reference value of τ is 1, which corresponds to 84 days, that is, the planned duration of regimen-DI. The reference value of δ is 1, which corresponds to 450 mg/m2 of doxorubicin plus 600 mg/m2 of cisplatin.